Coherus Oncology (NasdaqGM:CHRS) FY Conference January 13, 2026 01:30 PM ET Company ParticipantsTheresa LaVallee - Chief Scientific and Development OfficerDennis Lanfear - CEOConference Call ParticipantsBrian Cheng - Senior Biotech AnalystBrian ChengGood morning, everyone. It's still the morning. Thanks for joining us for another session at the 44th JPMorgan healthcare conference. I'm Brian Cheng. I'm one of the Senior Biotech Analysts here at the firm. On stage, we have the team from Coherus Oncology. I wi ...